NH THERAGUIX has a total of 29 patent applications. It increased the IP activity by 566.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, medical technology and micro-structure and nano-technology are MEDINOVA MED CONSULTING GMBH, ORBUS PHARMA INC and JINIS CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | Canada | 3 | |
#4 | China | 3 | |
#5 | Republic of Korea | 3 | |
#6 | Taiwan | 3 | |
#7 | France | 2 | |
#8 | United States | 2 | |
#9 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Micro-structure and nano-technology | |
#4 | Materials and metallurgy |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Electrotherapy | |
#4 | Nanostructure applications | |
#5 | Inorganic compounds | |
#6 | Non-metallic elements |
# | Name | Total Patents |
---|---|---|
#1 | Tillement Olivier | 29 |
#2 | Lux François | 14 |
#3 | Lux Francois | 14 |
#4 | Allouch Awatef | 9 |
#5 | Deutsch Eric | 9 |
#6 | Rosseti Fabien | 8 |
#7 | Tran Vu Long | 8 |
#8 | Perfettini Jean-Luc | 8 |
#9 | Dahan Myleva | 8 |
#10 | Rossetti Fabien | 7 |
Publication | Filing date | Title |
---|---|---|
EP3795178A1 | Methods for triggering m1 macrophage polarization | |
FR3099883A1 | Nanoparticles for the treatment of cancer by radiofrequency radiation | |
WO2021019268A1 | Methods for treating tumors | |
CN110933934A | Method for synthesizing silica nanoparticles | |
AU2017371069A1 | Bismuth-gadolinium nanoparticles | |
FR3072281A1 | NANOVECTORS AND USES, IN PARTICULAR FOR THE TREATMENT OF TUMORS | |
EP3424533A1 | Methods for treating tumors |